Moderna Operating Margin from 2010 to 2026
| 0QF Stock | EUR 44.24 1.45 3.39% |
Check Moderna financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Moderna's main balance sheet or income statement drivers, such as Net Interest Income of 484.2 M, Interest Income of 513.2 M or Interest Expense of 15.3 M, as well as many indicators such as Price To Sales Ratio of 5.61, Dividend Yield of 4.0E-4 or PTB Ratio of 1.26. Moderna financial statements analysis is a perfect complement when working with Moderna Valuation or Volatility modules.
Moderna | Operating Margin |
The Operating Margin trend for Moderna offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Moderna is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Moderna's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Moderna over the last few years. It is Moderna's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Moderna's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (1.26) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Moderna Operating Margin Regression Statistics
| Arithmetic Mean | (1.95) | |
| Coefficient Of Variation | (107.63) | |
| Mean Deviation | 1.11 | |
| Median | (2.06) | |
| Standard Deviation | 2.09 | |
| Sample Variance | 4.39 | |
| Range | 9.8134 | |
| R-Value | 0.19 | |
| Mean Square Error | 4.51 | |
| R-Squared | 0.04 | |
| Significance | 0.47 | |
| Slope | 0.08 | |
| Total Sum of Squares | 70.21 |
Moderna Operating Margin History
About Moderna Financial Statements
Moderna stakeholders use historical fundamental indicators, such as Moderna's Operating Margin, to determine how well the company is positioned to perform in the future. Although Moderna investors may analyze each financial statement separately, they are all interrelated. For example, changes in Moderna's assets and liabilities are reflected in the revenues and expenses on Moderna's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Moderna. Please read more on our technical analysis and fundamental analysis pages.
Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts. MODERNA INC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1800 people.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Moderna Correlation against competitors. For more detail on how to invest in Moderna Stock please use our How to Invest in Moderna guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.